» Articles » PMID: 33565152

Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells

Overview
Journal Ann Neurol
Specialty Neurology
Date 2021 Feb 10
PMID 33565152
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In amyotrophic lateral sclerosis (ALS), early diagnosis is essential for both current and potential treatments. To find a supportive approach for the diagnosis, we constructed an artificial intelligence-based prediction model of ALS using induced pluripotent stem cells (iPSCs). Images of spinal motor neurons derived from healthy control subject and ALS patient iPSCs were analyzed by a convolutional neural network, and the algorithm achieved an area under the curve of 0.97 for classifying healthy control and ALS. This prediction model by deep learning algorithm with iPSC technology could support the diagnosis and may provide proactive treatment of ALS through future prospective research. ANN NEUROL 2021;89:1226-1233.

Citing Articles

Predictive modeling of ALS progression: an XGBoost approach using clinical features.

Gupta R, Bhandari M, Grover A, Al-Shehari T, Kadrie M, Alfakih T BioData Min. 2024; 17(1):54.

PMID: 39623504 PMC: 11610297. DOI: 10.1186/s13040-024-00399-5.


Machine learning and brain-computer interface approaches in prognosis and individualized care strategies for individuals with amyotrophic lateral sclerosis: A systematic review.

Kew S, Mok S, Goh C MethodsX. 2024; 13:102765.

PMID: 39286440 PMC: 11403252. DOI: 10.1016/j.mex.2024.102765.


A literature review: machine learning-based stem cell investigation.

Ara J, Khatun T Ann Transl Med. 2024; 12(3):52.

PMID: 38911568 PMC: 11193562. DOI: 10.21037/atm-23-1937.


The use of artificial intelligence in induced pluripotent stem cell-based technology over 10-year period: A systematic scoping review.

Vo Q, Saito Y, Ida T, Nakamura K, Yuasa S PLoS One. 2024; 19(5):e0302537.

PMID: 38771829 PMC: 11108174. DOI: 10.1371/journal.pone.0302537.


Phototoxicity avoidance is a potential therapeutic approach for retinal dystrophy caused by EYS dysfunction.

Otsuka Y, Imamura K, Oishi A, Asakawa K, Kondo T, Nakai R JCI Insight. 2024; 9(8).

PMID: 38646933 PMC: 11141876. DOI: 10.1172/jci.insight.174179.


References
1.
Philbrick K, Yoshida K, Inoue D, Akkus Z, Kline T, Weston A . What Does Deep Learning See? Insights From a Classifier Trained to Predict Contrast Enhancement Phase From CT Images. AJR Am J Roentgenol. 2018; 211(6):1184-1193. DOI: 10.2214/AJR.18.20331. View

2.
Fujimori K, Ishikawa M, Otomo A, Atsuta N, Nakamura R, Akiyama T . Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018; 24(10):1579-1589. DOI: 10.1038/s41591-018-0140-5. View

3.
Brooks B, Miller R, Swash M, Munsat T . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001; 1(5):293-9. DOI: 10.1080/146608200300079536. View

4.
Causey J, Zhang J, Ma S, Jiang B, Qualls J, Politte D . Highly accurate model for prediction of lung nodule malignancy with CT scans. Sci Rep. 2018; 8(1):9286. PMC: 6006355. DOI: 10.1038/s41598-018-27569-w. View

5.
Maurel C, Dangoumau A, Marouillat S, Brulard C, Chami A, Hergesheimer R . Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration. Mol Neurobiol. 2018; 55(8):6480-6499. DOI: 10.1007/s12035-017-0856-0. View